抗逆流性尿路支架可以预防支架相关症状:随机对照试验的元分析
Mohammed Zain Ulabedin Adhoni1, Ammar Al Homsi2, Zubeir Ali1
1Urology, Royal London Hospital, London, GBR.
Cureus
|December 26, 2023
概括
与标准支架相比,抗逆流性尿路支架显著减少疼痛和不适. 这一系统性审查建议在接受尿路支架的患者中使用它们,以改善结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医疗器械 医疗器械
- 临床试验 临床试验
背景情况:
- 尿道支架在泌尿器科手术中很常见.
- 与支架相关的不良症状 (SRS),如疼痛和尿动频率是常见的.
- 抗逆流性尿路支架的目的是尽量减少这些症状和膀回流 (VUR).
研究的目的:
- 评估抗逆流性尿路支架与常规支架在减少SRS中的有效性.
- 进行随机对照试验 (RCT) 的系统审查和元分析.
主要方法:
- 三个RCT的系统审查和元分析.
- 包括总共269个案件.
- 对抗逆流和标准尿路支架之间的结果进行比较.
主要成果:
- 抗逆流体支架显著减少了支架相关的疼痛 (OR:4.80) 和严重的支架相关的疼痛 (OR:8.35).
- 排尿时侧侧疼痛也显著减少 (OR:5.98),包括严重的病例 (OR:15.79).
- 在术后肌氨酸异常或水中没有观察到显著差异.
结论:
- 抗逆流性尿路支架在缓解SRS方面比标准支架更有效.
- 建议在接受尿路支架的患者考虑使用抗逆流的尿路支架.
相关概念视频
Peptic Ulcer Disease IV: Management
95
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95
Gastroesophageal Reflux Disease II: Clinical Features and Management
88
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
88
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
445
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
445
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
129
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
129
Esophageal Strictures-II: Clinical Features and Management
73
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
73


